QuantLogix ← ABBV scorecard
📅 ABBV Earnings Preview
ABBVIE INC.
Next report (est.)
11/02/2026
Countdown
5 days
EPS growth YoY
+290.4%
Revenue growth YoY
+10.2%
Options-implied earnings move
±4.2%
The at-the-money straddle prices a move to roughly $298.40 or $274.20 from $286.30 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/03/2026 ±3.2% -2.3% over-priced
05/08/2026 ±2.1% -0.6% over-priced
02/20/2026 ±3.0% +0.2% over-priced
11/04/2025 ±3.0% +1.9% over-priced
08/04/2025 ±3.3% +1.0% over-priced
05/09/2025 ±3.2% -0.5% over-priced
02/14/2025 ±1.7% -0.3% over-priced
11/04/2024 ±2.7% -1.5% over-priced
Across these reports, options implied an average ±2.8% move vs an actual average of 1.0% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $2.03 $17.0B $3.6B
Q1 FY2026 $0.39 $15.0B $695M
Q4 FY2025 $1.02 $16.6B $1.8B
Q3 FY2025 $0.10 $15.8B $186M
Analyst posture
Buy / Strong Buy
32
Hold
7
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 86/100 Full scorecard →
Get alerted before every ABBV report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on ABBV before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

ABBVIE INC. (ABBV) reports in 5 days, with the next report estimated for 11/02/2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced ABBV's earnings risk. Fundamentals into the print: EPS up 290.4% year-over-year, revenue up 10.2%. QuantLogix's live 5-factor engine currently reads ABBV as a buy at 86/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →